A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS
Keith Henry, Alejo Erice, Camlin Tierney, Henry H. Balfour, Margaret A. Fischl, Anne Kmack, Song Heng Liou, Antoinette Kenton, Martin S. Hirsch, John Phair, Ana Martinez, James O. Kahn
Dive into the research topics of 'A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS'. Together they form a unique fingerprint.